News archives 2022.04

Home > 2022.04

2022.04.27

Completion of the Series C funding to advance pipeline of novel GPCR antibodies

NBHL has completed 7.64 million USD of the Series C funding to advance pipeline of novel GPCR antibodies.

Click here for detail.